SMTL ID : 7sn2.1

Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 2 residues within 4Å: Chain A: N.331, I.332 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- MAN- NAG- MAN- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-MAN-NAG.2: 10 residues within 4Å: Chain A: F.338, G.339, F.342, N.343, V.367, S.371 Chain C: E.23, Q.49, N.115, W.116 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:E.23

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nabel, K.G. et al., Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Science (2022)

Release Date

2021-12-08

Peptides

Spike glycoprotein: A
neutralizing antibody C1C-A3 Fab heavy chain: B
neutralizing antibody C1C-A3 Fab light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

C
L

Spike glycoprotein

neutralizing antibody C1C-A3 Fab heavy chain

neutralizing antibody C1C-A3 Fab light chain

Related Entries With Identical Sequence